We have placed cookies on your computer to help make this website better. We use a Matomo Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by Matomo (e.g. deny use/opt-out).

The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. We are a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 155 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

Beyond our overarching purpose – to improve the health of people around the globe – we want to create shared value through sustainability for our company and society as a whole.

... Responsibility

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

We believe that success comes from close collaborations founded on a shared vision to develop innovative medicines for patients that suffer from diseases with high unmet needs.

... Partnering

We strengthen and develop our core markets Europe, North America, Latin America and Asia through acquisitions, asset deals, in-licensing, commercialization and distribution deals.

... Areas of interest

We work with the world’s biggest public-private partnership organisation in the life sciences as co-leaders of the latest pain initiative.

... Public Private Partnerships

Good business

Good business means taking responsibility for the communities and wider world around us.
We do not just think about today but tomorrow too, acting with future generations in mind and doing all we can to minimize our impact on the environment.

As detailed in our Code of Conduct and Environment, Health & Safety policies, we work within occupational health and safety guidelines and comply with all relevant laws, internationally recognized guidelines and industry standards.

We are proud of every step we make, but are determined to do more. Beyond our overarching purpose – to improve the health of people around the globe, working with our customers and partners we want to create shared value through sustainability for our company and society as a whole.

Compliance

We observe high standards of integrity and honesty to ensure we follow our Code of Conduct.

... Learn more about Compliance at Grünenthal

A Heart for people

Imagine a world free of pain. We can – and we do all we can to make it a reality. Caring for the world around us is a big part of who we are – from a patient’s pain to climate change – we are committed to doing what we can to tackle these issues, big and small.

... Read about our social commitment.